Please use this identifier to cite or link to this item:
Title: Molecular modeling of the human eukaryotic translation initiation factor 5A (eIF5A) based on spectroscopic and computational analyses
Authors: Costa-Neto, Claudio M.
Parreiras-e-Silva, Lucas T.
Ruller, Roberto
Oliveira, Eduardo B.
Miranda, Antonio
Oliveira, Laerte
Ward, Richard J.
Universidade de São Paulo (USP)
Universidade Federal de São Paulo (UNIFESP)
Keywords: eIF5A
circular dichroism
Issue Date: 1-Sep-2006
Publisher: Elsevier B.V.
Citation: Biochemical and Biophysical Research Communications. San Diego: Academic Press Inc Elsevier Science, v. 347, n. 3, p. 634-640, 2006.
Abstract: The eukaryotic translation initiation factor 5A (eIF5A) is a protein ubiquitously present in archaea and eukarya, which undergoes a unique two-step post-translational modification called hypusination. Several studies have shown that hypusination is essential for a variety of functional roles for eIF5A, including cell proliferation and synthesis of proteins involved in cell cycle control. Up to now neither a totally selective inhibitor of hypusination nor an inhibitor capable of directly binding to cIF5A has been reported in the literature. the discovery of such an inhibitor might be achieved by computer-aided drug design based on the 3D structure of the human eIF5A. in this study, we present a molecular model for the human eIF5A protein based on the crystal structure of the eIF5A from Leishmania brasiliensis, and compare the modeled conformation of the loop bearing the hypusination site with circular dichroism data obtained with a synthetic peptide of this loop. Furthermore, analysis of amino acid variability between different human eIF5A isoforms revealed peculiar structural characteristics that are of functional relevance. (c) 2006 Elsevier Inc. All rights reserved.
ISSN: 0006-291X
Other Identifiers:
Appears in Collections:Artigo

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.